Real-world experience of regorafenib in patients with hepatocellular carcinoma: A multicenter United Kingdom study

被引：0
|
作者：
Ross, Paul J.
Ma, Yuk Ting
Palmer, Daniel H.
Lythgoe, Mark Peter
Merrick, Sophie
Samson, Adel
Rao, Ankit Rohit
Basu, Bristi
Prasad, Debi
Dhillon, Tony
Lau, David
Darby, Suzanne
Orr, James
Margetts, Jane
Hubner, Richard
Baijal, Shobhit
Sharma, Rohini
Faluyi, Olusola Olusesan
Lee, Lennard
Thillai, Kiruthikah
机构：
[1] Guys & St Thomas NHS Fdn Trust, London, England
[2] Kings Coll Hosp NHS Fdn Trust, London, England
[3] Univ Birmingham, Birmingham, W Midlands, England
[4] Univ Liverpool, Liverpool, Merseyside, England
[5] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[6] Imperial Coll London, London, England
[7] East & North Herts NHS Trust, Stevenage, Herts, England
[8] Univ Leeds, Leeds, W Yorkshire, England
[9] Nottingham City Hosp, Nottingham, England
[10] Univ Cambridge, Cambridge, England
[11] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[12] Kings Coll Hosp London, London, England
[13] Univ Surrey, Royal Surrey Hosp, Guildford, Surrey, England
[14] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[15] Weston Pk Hosp, Sheffield, S Yorkshire, England
[16] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England
[17] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[18] Christie NHS Fdn Trust, Manchester, Lancs, England
[19] Birmingham Heartlands Hosp, Birmingham, W Midlands, England
[20] Clatterbridge Canc Ctr, Wirral, Merseyside, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
499
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A nationwide multicenter study of Japanese patients with unresectable hepatocellular carcinoma treated with regorafenib in real-world practice
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Sakamoto, Azusa
    Matusawa, Hiroyuki
    Hasebe, Chitomi
    Abe, Takehiko
    Joko, Kouji
    Ogawa, Chikara
    Furuta, Koichiro
    Kusakabe, Atsunori
    Kobashi, Haruhiko
    Kimura, Hiroyuki
    Matsushita, Tomomichi
    Uchida, Yasushi
    Izumi., Namiki
    JOURNAL OF HEPATOLOGY, 2020, 73 : S911 - S911
  • [2] Regorafenib combined with immunotherapy versus regorafenib as second-line therapy in patients with advanced hepatocellular carcinoma: A multicenter real-world study
    Li, B-K.
    Yuan, Y.
    Qiao, L.
    He, W.
    Wang, G.
    Chen, H.
    Zhang, B.
    Fuxi, H.
    Qiu, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S596 - S596
  • [3] Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study
    Qiao, Liang
    He, Wei
    Wang, Guoying
    Chen, Huanwei
    Huang, Fuxi
    Zhang, Bo
    Qiu, Yuxiong
    Liu, Shaoru
    Huang, Zhenkun
    Yuan, Yichuan
    Qiu, Jiliang
    Yuan, Yunfei
    Li, Binkui
    CANCER MEDICINE, 2024, 13 (09):
  • [4] Multicenter, real-world experience with lenvatinib for patients with advanced hepatocellular carcinoma in Japan
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Nakai, Masato
    Morikawa, Kenichi
    Sakamoto., Naoya
    JOURNAL OF HEPATOLOGY, 2020, 73 : S909 - S909
  • [5] Immunotherapy combination with regorafenib for refractory hepatocellular carcinoma: A real-world study
    Tu, Xinyue
    Yang, Jing
    Zheng, Yingbin
    Liang, Chen
    Tao, Qiang
    Tang, Xiang
    Liu, Zonghao
    Jiang, Lingmin
    He, Zhaoqian
    Xie, Feihu
    Zheng, Yun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [6] Efficacy and safety of regorafenib alone or in combinations for advanced hepatocellular carcinoma: A multicenter real-world study.
    Zhu, Haidong
    Zhu, Xiaoli
    Song, Yusheng
    Wang, Qi
    Wu, Jianbing
    Xu, Hao
    Teng, Gaojun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16122 - E16122
  • [7] Real-world experience of trifluridine/tipiracil in patients with metastatic colorectal cancer: A multicenter United Kingdom study.
    Stavraka, Chara
    Pouptsis, Athanasios
    Kabuubi, Paul
    Angelis, Vasileios
    Synowiec, Alicja
    Baxter, Mark
    Barrie, Ainsley
    Costa, Amparo Andres
    Nizam, Alia
    De Naurois, Julien
    Mikropoulos, Christos
    Hill, Mark
    Graham, Janet Shirley
    Harris, Victoria
    Bridgewater, John A.
    Ross, Paul J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [8] Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Lee, Min Jin
    Chang, Sung Won
    Kim, Ji Hoon
    Lee, Young-Sun
    Cho, Sung Bum
    Seo, Yeon Seok
    Yim, Hyung Joon
    Hwang, Sang Youn
    Lee, Hyun Woong
    Chang, Young
    Jang, Jae Young
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 260 - 268
  • [9] Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Min Jin Lee
    Sung Won Chang
    Ji Hoon Kim
    Young-Sun Lee
    Sung Bum Cho
    Yeon Seok Seo
    Hyung Joon Yim
    Sang Youn Hwang
    Hyun Woong Lee
    Young Chang
    Jae Young Jang
    Investigational New Drugs, 2021, 39 : 260 - 268
  • [10] The real-world systemic sequential therapy of sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Lee, Yoonseok
    Chang, Sung Won
    Lee, Min-Jin
    Kim, Ji Hoon
    Bang, Soo Min
    Kim, Sehwa
    Lee, Young-Sun
    Cho, Sung Bum
    Seo, Yeon Seok
    Yim, Hyung Joon
    Hwang, Sang Youn
    Lee, Hyun Woong
    Chang, Young
    Jang., Jae Young
    JOURNAL OF HEPATOLOGY, 2020, 73 : S909 - S909
12345